2,960
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Platelet to white blood cell ratio was an independent prognostic predictor in acute myeloid leukemia

, , , &

References

  • Bain BJ, Bene MC. Morphological and immunophenotypic clues to the WHO categories of acute myeloid leukaemia. Acta Haematol. 2019;141(4):232–244.
  • Cai SF, Levine RL. Genetic and epigenetic determinants of AML pathogenesis. Semin Hematol. 2019;56(2):84–89.
  • de Jonge HJ, Huls G, de Bont ES. Gene expression profiling in acute myeloid leukaemia. Neth J Med. 2011;69(4):167–176.
  • Boyiadzis M, Whiteside TL. Exosomes in acute myeloid leukemia inhibit hematopoiesis. Curr Opin Hematol. 2018;25(4):279–284.
  • Lou Y, Ma Y, Sun J, et al. Effectivity of a modified Sanz risk model for early death prediction in patients with newly diagnosed acute promyelocytic leukemia. Ann Hematol. 2017;96(11):1793–1800.
  • Chen Z, Huang Y, Li S, et al. Platelet-to-white blood cell ratio: A prognostic predictor for 90-day outcomes in ischemic stroke patients with intravenous thrombolysis. J Stroke Cerebrovasc Dis Official J National Stroke Assoc. 2016;25(10):2430–2438.
  • Jie Y, Gong J, Xiao C, et al. Low platelet to white blood cell ratio indicates poor prognosis for acute-on-chronic liver failure. BioMed Res Int. 2018;2018:7394904.
  • Garbens A, Wallis CJD, Bjarnason G, et al. Platelet to white blood cell ratio predicts 30-day postoperative infectious complications in patients undergoing radical nephrectomy for renal malignancy. Canadian Urol Assoc J. 2017;11(11):E414–E420.
  • Wang JH, Chen WL, Li JM, et al. Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China. Proc Natl Acad Sci U S A. 2013;110(42):17017–17022.
  • Wang J, Li F, Ma Z, et al. High expression of TET1 predicts poor survival in cytogenetically normal acute myeloid leukemia from Two cohorts. EBioMedicine. 2018;28:90–96.
  • Ma QL, Wang JH, Wang YG, et al. High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia. Int J Cancer. 2015;137(5):1058–1065.
  • Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337–344.
  • Kelaidi C, Ades L, Fenaux P. Treatment of acute promyelocytic leukemia with high white cell blood counts. Mediterr J Hematol Infect Dis. 2011;3(1):e2011038.